Investment analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
CALA stock opened at $0.00 on Friday. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.12. The stock’s fifty day moving average is $0.02 and its two-hundred day moving average is $0.02.
Calithera Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Calithera Biosciences
- How to Use the MarketBeat Excel Dividend Calculator
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Stock Market Sectors: What Are They and How Many Are There?
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Insider Buying Explained: What Investors Need to Know
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.